tablets "ATs-FS" are applied for treatment of the sharp and chronic diseases of a bronchopulmonary system demanding reduction of viscosity of a phlegm, improvement of its otkhozhdeniye and expectoration.

Structure

Active ingredient - Acetylcysteinum (one tablet contains Acetylcysteinum 200 mg).

Excipients: cellulose microcrystalline, lactose monohydrate (tabletoza), starch corn, magnesium stearate, a covering for drawing a cover of Opadry II White (polyethyleneglycol, polyvinyl alcohol, talc, the titan dioxide (E 171)).

Contraindication

• hypersensitivity to Acetylcysteinum or to any component of medicine;
• a peptic ulcer of a stomach and duodenum in an aggravation stage;
• pulmonary bleeding;
• pneumorrhagia;
• heavy exacerbation of asthma.

Route of administration

Drug "ATs-FS" is appointed inside:

• to adults and children is more senior than 14 years - on 200 mg 2-3 times a day;
• to children aged from 6 up to 14 years - on 200 mg 2 times a day.

after a meal, to swallow of a pill without chewing, washing down with enough water.

Duration of application is defined by the doctor depending on disease severity and the clinical response to treatment. It is not necessary to take the medicament more than 4-5 days without consultation with the doctor.

during treatment by Acetylcysteinum recommends additional intake of liquid for strengthening of mucolytic effect.

Feature of application

Pregnant

Knows that clinical data on use of Acetylcysteinum by pregnant women are limited. There are data that researches on animals did not reveal straight lines or indirect negative impacts on pregnancy, embrio-fetal development, childbirth and post-natal development.

Feeding by a breast. Information on penetration into breast milk is absent.

it is necessary to Take the medicament during pregnancy and feeding by a breast only after careful assessment of a ratio advantage/risk.

Children

Considering a dosage form, medicine not to appoint to children up to 6 years.

Drivers

Data on negative impact of medicine on speed of response at control of vehicles and other mechanisms are absent.

Overdose

Is not present data on overdose cases at oral administration of Acetylcysteinum.

Symptoms: the overdose can be shown by gastrointestinal symptoms, such as nausea, vomiting and diarrhea. For children there is a risk of hypersecretion.

Therapy: there is no specific antidote at poisoning with Acetylcysteinum, symptomatic treatment.

Frequency of side reactions is determined by

by classification: very often (≥ 10%), it is frequent (≥ 1%, <10%), infrequently (≥ 0.1%, <1%), single (≥ 0.01%, <0.1%), rare (<0.01%), frequency is unknown (the obtained data do not allow to estimate frequency).

from the immune system: infrequently - hypersensitivity; rare - an acute anaphylaxis, anaphylactic/anaphylactoid reactions.

from blood and lymphatic system: frequency is unknown - anemia.

from a cardiovascular system: infrequently - tachycardia, arterial hypotension; rare - hemorrhages.

from nervous system: infrequently - a headache.

from organs of hearing and a labyrinth: infrequently - ring/sonitus.

from a respiratory system: single - short wind, a bronchospasm (mainly at patients with hyperreactivity of a bronchial system, is associated with bronchial asthma); frequency is unknown - a rhinorrhea.

from a digestive tract: seldom - heartburn, nausea, vomiting, an abdominal pain, diarrhea, stomatitis; rare - dyspepsia; frequency is unknown - an unpleasant smell from a mouth.

from skin and hypodermic fabrics: infrequently - an itch, urticaria, rash, a Quincke's edema; frequency is unknown - rash, eczema, a Quincke's disease.

to

At use of Acetylcysteinum it was reported about separate cases of heavy reactions from skin (Stephens-Johnson's syndrome and a Lyell's disease), exceptional cases of developing of bleedings were observed, were most often connected with development of reactions of hypersensitivity.

to

It was reported about separate cases of anaphylactic reaction or even shock, anemia cases. In most cases, at least, one more medicine can be the cause of emergence of a skin and mucous syndrome more likely. In case of changes of skin or a mucous membrane it is necessary to see immediately a doctor and to stop use of Acetylcysteinum.

by

noted cases of suppression of aggregation of platelets, however that does not have clinical confirmation.

in case of any undesirable manifestations needs to consult to the doctor about a possibility of further use of medicine.

Storage conditions

to Store

in original packing at a temperature not above 25 °C, out of children's reach.

an expiration date - 3 years.